Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.460
-0.060 (-2.38%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Acumen Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 178 | 128 | 103 | 222 | 221 | 274 | |
| Market Cap Growth | 164.21% | 23.68% | -53.53% | 0.62% | -19.22% | - | |
| Enterprise Value | 92 | 23 | -126 | -60 | 21 | 44 | |
| Last Close Price | 2.46 | 2.11 | 1.72 | 3.84 | 5.40 | 6.76 | |
| PB Ratio | 2.12 | 1.82 | 0.57 | 0.83 | 1.17 | 1.22 | |
| P/TBV Ratio | 2.52 | 1.82 | 0.57 | 0.83 | 1.17 | 1.22 | |
| Debt / Equity Ratio | 0.45 | 0.45 | 0.16 | 0.12 | 0.00 | - | |
| Net Debt / Equity Ratio | -1.22 | -1.22 | -1.11 | -1.03 | -1.02 | -1.00 | |
| Net Debt / EBITDA Ratio | 0.69 | 0.69 | 1.77 | 4.50 | 4.28 | 11.54 | |
| Net Debt / FCF Ratio | 0.74 | 0.74 | 2.34 | 6.38 | 5.48 | 12.55 | |
| Inventory Turnover | - | - | - | 284.97 | 229.51 | 141.44 | |
| Quick Ratio | 3.93 | 3.93 | 6.24 | 18.81 | 22.75 | 37.76 | |
| Current Ratio | 4.07 | 4.07 | 6.46 | 19.01 | 23.08 | 38.60 | |
| Return on Equity (ROE) | -96.20% | -96.20% | -45.60% | -22.98% | -20.71% | -76.44% | |
| Return on Assets (ROA) | -42.78% | -42.78% | -25.96% | -15.08% | -13.25% | -8.91% | |
| Return on Capital Employed (ROCE) | -133.40% | -133.40% | -53.90% | -20.60% | -24.00% | -8.70% | |
| Earnings Yield | -68.30% | -94.93% | -99.02% | -23.55% | -19.39% | -36.77% | |
| FCF Yield | -65.09% | -90.47% | -83.45% | -19.38% | -15.98% | -6.58% | |
| Buyback Yield / Dilution | -0.91% | -0.91% | -23.46% | -19.72% | -102.43% | -4685.59% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.